Indivior PLC | Balance Sheet

Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4
212
317
560
638
726
Total Accounts Receivable
103
110
132
198
218
250
Inventories
22
26
33
33
38
61
Other Current Assets
8
14
8
10
11
7
Total Current Assets
138
362
489
801
906
1,043
Net Property, Plant & Equipment
8
8
22
22
40
45
Long-Term Note Receivable
7
-
-
-
11
26
Intangible Assets
57
58
42
67
68
66
Other Assets
-
1
-
-
-
-
Total Assets
257
479
636
978
1,067
1,215
ST Debt & Current Portion LT Debt
-
11
23
82
4
Accounts Payable
33
194
271
352
350
Income Tax Payable
10
40
28
42
30
Other Current Liabilities
229
52
87
358
248
Total Current Liabilities
272
296
409
834
631
Long-Term Debt
-
461
387
351
353
Provision for Risks & Charges
25
26
28
32
234
Deferred Taxes
48
49
83
88
43
Total Liabilities
297
784
825
1,217
1,218
Common Equity (Total)
40
305
189
239
150
Total Shareholders' Equity
40
305
189
239
150
Total Equity
40
305
189
239
150
Liabilities & Shareholders' Equity
257
479
636
978
1,067

About Indivior

View Profile
Address
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
Employees -
Website http://indivior.com/
Updated 07/08/2019
Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.